نتایج جستجو برای: regorafenib

تعداد نتایج: 831  

Journal: :Frontiers in Oncology 2023

Background The objective of this study is to evaluate the efficacy and safety different third-line treatment regimens for metastatic colorectal cancer (mCRC) through a comprehensive analysis network meta-analysis (NMA). Additionally, aims provide guidance on selecting appropriate systemic patients with mCRC. Methods We conducted search PubMed, Embase, Web Science, Cochrane Central Register Cont...

Journal: :The Turkish Journal of Gastroenterology 2018

Journal: :Annals of oncology : official journal of the European Society for Medical Oncology 2014
S Napolitano E Martinelli D Vitagliano G Martini C Cardone F De Vita F Ciardiello T Troiani

Methods:We have tested, in vitro and in vivo, the effects of regorafenib, a novel oral multikinase inhibitor that targets protein kinases involved in tumor angiogenesis [VEGFR1–3 and tyrosine kinase with immunoglobulin and epidermal growth factor homology domain 2 (TIE2)], oncogenesis (KIT, RET and RAF) and the tumor microenvironment [plateletderived growth factor receptor-b and fibroblast grow...

Journal: :Journal of cellular physiology 2015
Jane L Roberts Mehrad Tavallai Aida Nourbakhsh Abigail Fidanza Tanya Cruz-Luna Elizabeth Smith Paul Siembida Pascale Plamondon Kelly A Cycon Christopher D Doern Laurence Booth Paul Dent

Prior tumor cell studies have shown that the drugs sorafenib (Nexavar) and regorafenib (Stivarga) reduce expression of the chaperone GRP78. Sorafenib/regorafenib and the multi-kinase inhibitor pazopanib (Votrient) interacted with sildenafil (Viagra) to further rapidly reduce GRP78 levels in eukaryotes and as single agents to reduce Dna K levels in prokaryotes. Similar data were obtained in tumo...

Journal: :Clinical advances in hematology & oncology : H&O 2016
Benjamin A Weinberg John L Marshall Mohamed E Salem

Colorectal cancer (CRC) is the second leading cause of cancer-related death in the United States. Approximately 20% of patients have metastatic disease at diagnosis, and a vast number of these patients die within 5 years. The advent of modern chemotherapeutics has improved median overall survival for these patients; nonetheless, we must keep striving for better outcomes. Trifluridine/tipiracil ...

2015

Drugs and other chemicals frequently bind nonspecifically to the constituents of an in vitro incubation mixture, particularly the enzyme source [e.g., human livermicrosomes (HLM)]. Correction for nonspecific binding (NSB) is essential for the accurate calculation of the kinetic parameters Km, Clint, and Ki. Many tyrosine kinase inhibitors (TKIs) are lipophilic organic bases that are nonionized ...

Journal: :Drug metabolism and disposition: the biological fate of chemicals 2015
Kushari Burns Pramod C Nair Andrew Rowland Peter I Mackenzie Kathleen M Knights John O Miners

Drugs and other chemicals frequently bind nonspecifically to the constituents of an in vitro incubation mixture, particularly the enzyme source [e.g., human liver microsomes (HLM)]. Correction for nonspecific binding (NSB) is essential for the accurate calculation of the kinetic parameters Km, Clint, and Ki. Many tyrosine kinase inhibitors (TKIs) are lipophilic organic bases that are nonionized...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید